Evidence map›Paper›PMID 35203598›Full record

ArticleBiomedicines2022

Identification of Potential Targets Linked to the Cardiovascular/Alzheimer's Axis through Bioinformatics Approaches.

Francisco Andújar-Vera, Cristina García-Fontana, Raquel Sanabria-de la Torre, Sheila González-Salvatierra, Luis Martínez-Heredia, Iván Iglesias-Baena, Manuel Muñoz-Torres, Beatriz García-Fontana

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Francisco Andújar-VeraInstituto de Investigación Biosanitaria de Granada, 18012 Granada, Spain.ORCID 0000-0002-2663-8809
Cristina García-FontanaInstituto de Investigación Biosanitaria de Granada, 18012 Granada, Spain.ORCID 0000-0002-9328-6022
Raquel Sanabria-de la TorreInstituto de Investigación Biosanitaria de Granada, 18012 Granada, Spain.ORCID 0000-0002-3261-6745
Sheila González-SalvatierraInstituto de Investigación Biosanitaria de Granada, 18012 Granada, Spain.ORCID 0000-0002-6413-7001
Luis Martínez-HerediaInstituto de Investigación Biosanitaria de Granada, 18012 Granada, Spain.
Iván Iglesias-BaenaFundación para la Investigación Biosanitaria de Andalucía Oriental-Alejandro Otero (FIBAO), 18012 Granada, Spain.
Manuel Muñoz-TorresInstituto de Investigación Biosanitaria de Granada, 18012 Granada, Spain.ORCID 0000-0002-9645-3260
Beatriz García-FontanaInstituto de Investigación Biosanitaria de Granada, 18012 Granada, Spain.ORCID 0000-0002-4134-5561
Universidad de Granada · ESInstituto de Salud Carlos III · ESInstituto de Investigación Biosanitaria de Granada · ES

Funding

Instituto de Salud Carlos III CD20/00022Instituto de Salud Carlos III FI19/00118Instituto de Salud Carlos III PI18-00803Regional Government of Andalusia PI-0268-2019University of Granada 8110
6 · The paper itself

Abstract

The identification of common targets in Alzheimer's disease (AD) and cardiovascular disease (CVD) in recent years makes the study of the CVD/AD axis a research topic of great interest. Besides aging, other links between CVD and AD have been described, suggesting the existence of common molecular mechanisms. Our study aimed to identify common targets in the CVD/AD axis. For this purpose, genomic data from calcified and healthy femoral artery samples were used to identify differentially expressed genes (DEGs), which were used to generate a protein-protein interaction network, where a module related to AD was identified. This module was enriched with the functionally closest proteins and analyzed using different centrality algorithms to determine the main targets in the CVD/AD axis. Validation was performed by proteomic and data mining analyses. The proteins identified with an important role in both pathologies were apolipoprotein E and haptoglobin as DEGs, with a fold change about +2 and -2, in calcified femoral artery vs healthy artery, respectively, and clusterin and alpha-2-macroglobulin as close interactors that matched in our proteomic analysis. However, further studies are needed to elucidate the specific role of these proteins, and to evaluate its function as biomarkers or therapeutic targets.

Indexed as

Alzheimer’s diseasebioinformaticscardiovascular diseasedifferentially expressed geneshubsprotein–protein interaction network

Identifiers

PMID35203598
PMCPMC8962298
OpenAlexW4210782008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.